Fatty Acid Cryopreservation Medium for Cell Viability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current cryopreservation methods for regenerative medicine products face challenges in minimizing cell death and maintaining quality during storage, particularly in central allogeneic regenerative medicine, where cells from a donor are cultured and processed centrally for use in patients, necessitating a cryopreservation technique that ensures high cell viability and quality after thawing.

Innovation Solution

A composition for cryopreservation containing fatty acids or fatty acid esters is used to immerse cells before freezing, which helps in preserving cells in a three-dimensional form, reducing cell death and maintaining cell viability and differentiation capabilities post-thawing.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional cryopreservation methods using serum and DMSO are employed, then cells can be stored and transported, but cell death increases and quality control becomes difficult

Engineering Contradiction:
Improvecell viability after cryopreservationVSAvoidcell death and contamination risk
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent removes serum and DMSO from the cryopreservation medium, extracting the harmful components while retaining the essential cryopreservation function. The serum-free formulation eliminates biological contamination risks and immunogenic substances, while the DMSO-free approach reduces cell toxicity and death.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention changes the chemical composition parameters of the cryopreservation medium by replacing traditional serum-based components with a defined chemical mixture containing amino acids, vitamins, and other essential nutrients. This parameter change maintains cell viability while eliminating harmful effects of conventional components.

Inventive Principle:
Principle #35Parameter changes

2Object-affected harmful factors

If serum-free chemically-defined medium is used, then contamination risks are minimized, but cryopreservation quality and cell recovery are compromised

Engineering Contradiction:
Improvebiological contamination and immunogenicityVSAvoidcell recovery and viability
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent creates a composite cryopreservation medium combining multiple chemically-defined components including amino acids, vitamins, minerals, and growth factors. This composite formulation provides all necessary nutrients for cell survival during freezing and thawing while maintaining the serum-free, contamination-free advantage.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The invention optimizes the concentration and composition of individual chemical components in the serum-free medium to enhance cell recovery. Specific parameters such as amino acid concentrations, vitamin types, and additive combinations are adjusted to improve cryopreservation effectiveness without compromising the chemically-defined nature of the medium.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The use of fatty acid-based compositions effectively reduces cell death and ensures good cell recovery and viability after cryopreservation and thawing, maintaining the cells' therapeutic properties, such as differentiation abilities, without relying on serum or other contaminants.

Implementation Method 1

a composition for cryopreservation of cells, the composition containing a fatty acid

Methodology Applied
Scientific EffectCryopreservation: Freezing

Implementation Method 2

The use of fatty acid-based compositions effectively reduces cell death and ensures good cell recovery and viability after cryopreservation and thawing

Methodology Applied
Scientific EffectCell membrane protection:

Data Source

PatentUS20200205399A1Composition for cryopreservation, method for producing cryopreserved material, cell preparation, method for producing cell preparation, and kit for cryopreservation
Publication Date: 2020.07.02 TWO CELLS
  • US20200205399A1 patent drawing
  • US20200205399A1 patent drawing
  • US20200205399A1 patent drawing

AI summary

An object is to achieve cryopreservation that yields no or few dead cells and that ensures good quality. A composition for cryopreservation in accordance with an aspect of the present invention is a composition for cryopreservation of cells, and contains a fatty acid.